Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2021.
Saved in:
| Title: | Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices -- United States, September 2021. |
|---|---|
| Authors: | Dooling, Kathleen1, Gargano, Julia W.1, Moulia, Danielle1, Wallace, Megan1, Rosenblum, Hannah G.1,2, Blain, Amy E.1, Hadler, Stephen C.1, Plumb, Ian D.1, Moline, Heidi1,2, Gerstein, Jack1, Collins, Jennifer P.1, Godfrey, Monica1, Campos-Outcalt, Doug3, Morgan, Rebecca L.4, Brooks, Oliver5, Talbot, H. Keipp6, Lee, Grace M.7, Daley, Matthew F.8, Oliver, Sara E.1 yxo4@cdc.gov |
| Source: | MMWR: Morbidity & Mortality Weekly Report. 9/24/2021, Vol. 70 Issue 38, p1344-1348. 5p. 2 Charts. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
